Bitting, R. L., Tooze, J. A., Petty, W. J., Grant, S. C., Desnoyers, R. J., Thomas, A., … Klepin, H. D. (2018). Phase I study of muscadine grape extract in advanced malignancy. In Journal of Clinical Oncology (Vol. 36, pp. e14548–e14548). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.e14548

Bitting, Rhonda L., Janet A. Tooze, William J. Petty, Stefan C. Grant, Rodwige J. Desnoyers, Alexandra Thomas, Christopher Y. Thomas, et al. “Phase I study of muscadine grape extract in advanced malignancy.” In Journal of Clinical Oncology, 36:e14548–e14548. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.e14548.

Bitting RL, Tooze JA, Petty WJ, Grant SC, Desnoyers RJ, Thomas A, et al. Phase I study of muscadine grape extract in advanced malignancy. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. e14548–e14548.

Bitting, Rhonda L., et al. “Phase I study of muscadine grape extract in advanced malignancy.” Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. e14548–e14548. Crossref, doi:10.1200/jco.2018.36.15_suppl.e14548.

Bitting RL, Tooze JA, Petty WJ, Grant SC, Desnoyers RJ, Thomas A, Thomas CY, Alistar AT, Golden S, Pleasant K, Tallant EA, Gallagher PE, Klepin HD. Phase I study of muscadine grape extract in advanced malignancy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. e14548–e14548.